investor.inva.com
Investor Overview : InnovivaThe Investor Relations website contains information about Innoviva business for stockholders, potential investors, and financial analysts.
http://investor.inva.com/
The Investor Relations website contains information about Innoviva business for stockholders, potential investors, and financial analysts.
http://investor.inva.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Saturday
LOAD TIME
1.5 seconds
PAGES IN
THIS WEBSITE
18
SSL
EXTERNAL LINKS
11
SITE IP
206.200.251.19
LOAD TIME
1.469 sec
SCORE
6.2
Investor Overview : Innoviva | investor.inva.com Reviews
https://investor.inva.com
The Investor Relations website contains information about Innoviva business for stockholders, potential investors, and financial analysts.
investor.inva.com
Stock Information : Innoviva
http://investor.inva.com/stockquote.cfm
4:00 PM ET on Mar 10, 2017. The stock information provided is for informational purposes only and is not intended for trading purposes. The stock information is provided by eSignal, stock charts are provided by EDGAR Online, both third party services, and Innoviva does not maintain or provide information directly to this service. Stock information is delayed approximately 20 minutes. Sign up for email alerts. 03/10/17 4:00 PM ET. Data provided by Nasdaq. Minimum 15 minutes delayed.
GSK Files Regulatory Submission in European Union for Once-Daily Closed Triple Combination Therapy FF/UMEC/VI for Patients with COPD (NASDAQ:INVA)
http://investor.inva.com/releasedetail.cfm?ReleaseID=1002397
Dec 2, 2016. File is in Briefcase. GSK Files Regulatory Submission in European Union for Once-Daily Closed Triple Combination Therapy FF/UMEC/VI for Patients with COPD. INVA) today announced the filing by GSK of a regulatory submission with the. Closed triple combination therapy comprises three medicines: fluticasone furoate, an inhaled corticosteroid (ICS), umeclidinium, a long-acting muscarinic antagonist (LAMA) and vilanterol, a long-acting beta. Head, Respiratory Therapy Area Unit, R&D, said, "Many p...
Download Library : Innoviva
http://investor.inva.com/downloads.cfm
File is in Briefcase. View Form 8937 - September 30, 2015. File is in Briefcase. View Form 8937 - August 5, 2015. File is in Briefcase. View Form 8937 - May 12, 2015. File is in Briefcase. Code of Business Conduct. File is in Briefcase. View Form 8937 - January 7, 2015. File is in Briefcase. View Form 8937 - July 15, 2014. File is in Briefcase. Theravance, Inc. Addendum to Conflict of Interest Policy with Regard to Theravance Biopharma, Inc. Matters. File is in Briefcase. File is in Briefcase.
Download Library : Innoviva
http://investor.inva.com/downloads.cfm?CategoryID=9639
View Form 8937 - September 30, 2015. File is in Briefcase. View Form 8937 - August 5, 2015. File is in Briefcase. View Form 8937 - May 12, 2015. File is in Briefcase. View Form 8937 - January 7, 2015. File is in Briefcase. View Form 8937 - July 15, 2014. File is in Briefcase. Add file to Briefcase. 03/10/17 4:00 PM ET. Data provided by Nasdaq. Minimum 15 minutes delayed. Sign up to receive important email alerts and updates from Innoviva. Innoviva Investor Relations and Media.
Press Releases : Innoviva
http://investor.inva.com/releases.cfm
Mar 7, 2017. Innoviva Files Preliminary Proxy Materials for 2017 Annual Meeting. Current Board's Strategic Plan has Produced Increased Royalty Revenue, Reduced Operating Expenses and Increased Net Income While Growing Stockholder Returns Sarissa Has Nominated a Slate to Replace a Majority of the Board and Has Provided No Rationale for its Actions nor Proposed a New Strategic . File is in Briefcase. Feb 28, 2017. Innoviva to Present at the Cowen and Co. 37th Annual Health Care Conference. Feb 23, 2017.
TOTAL PAGES IN THIS WEBSITE
18
Innoviva | About Innoviva
http://www.inva.com/about-innoviva
Presentations & Events. Presentations & Events. Innoviva is committed to building long-lasting value and improving patient care by partnering with companies that advance innovative therapies. Anchored by its respiratory assets, Innoviva blends a unique fusion of operational industry expertise and financial insight to create a solid foundation for capital returns and carve a path towards a healthier world for patients. Innoviva Vision and Values. We foster good science. We build on creativity. Innoviva is...
TOTAL LINKS TO THIS WEBSITE
11
INVESTOR OVERVIEW | Integra LifeSciences Holdings Corporation
Skip to main navigation. Annual Reports and Proxies. Stock Distribution (Tax Information). Annual Reports and Proxies. Stock Distribution (Tax Information). There are 45 results that match your search. You should be able to find several. Indispensable facts about motivation in the following paragraphs. If there’s at least one fact you didn’t know before, imagine the difference it migh. You should be able to find several. You should be able to find several. You should be able to find several. Indispensabl...
investor.internationalpaper.com
International Paper Company - Investor Relations
We deliver long-term value for all stakeholders by establishing advantaged positions in attractive, fiber-based market segments with safe, efficient manufacturing operations near sustainable fiber sources. Analyst Coverage and FAQs. Sell-side analysts covering our company and frequently asked questions from our investor community. Read the latest news about International Paper Company. Sharing information about our performance. Stock charts, quotes and more. We're Here To Help! Interested in Our Products?
Investor Relations | Intevac
Skip to main navigation. Mar 28, 2018. Intevac’s oDLC to Begin Shipping on Top 3 Cellphone Maker’s Flagship Smartphone. Mar 01, 2018. Intevac to Present Fan-Out Packaging Results at IMAPS Device Packaging Conference 2018. View all press releases. Mar 7, 2018 4:30 PM EST. 14th International Conference and Exhibition on Device Packaging. View all events and presentations. 12:20 AM EDT on Mar 30, 2018.
investor.intuitivesurgical.com
Intuitive Surgical - Investors - Investor Relations Home
Research and Educational Grants. Intuitive Surgical, Inc. (NASDAQ: ISRG) is the global technology leader in robotic-assisted minimally invasive surgery (MIS). The Company's da Vinci Surgical System offers surgeons superior visualization, enhanced dexterity, greater precision and ergonomic comfort for the optimal performance of MIS. The da Vinci System enables surgeons to perform even complex procedures such as open-heart surgery through 1-2 cm incisions. Learn More. 160; 8.92. Minimum 20 minute delay.
Inuvo, Inc. - Home
Inuvo Inc: Targeted Internet Marketing. Nominating, Corporate Governance and Compensation Commitee Charter. Date: Wednesday, February 7, 2018. Time: 4:15 pm ET. Http:/ public.viavid.com/player/index.php? Inuvo Reports Financial Results for the Fourth Quarter and Full Year Ending December 31, 2017. Inuvo to Announce 2017 Financial Results and Host Conference Call on Wednesday, February 7th. Inuvo Cyber Monday Revenue Increases Nearly 70% Year-Over-Year. Readers Vote Inuvo as a Best Place to Work. Inuvo to...
Investor Overview : Innoviva
Innoviva (NASDAQ: INVA) is focused on bringing compelling new medicines to patients in areas of unmet need by leveraging its significant expertise in the development, commercialization and financial management of bio-pharmaceuticals. Innoviva’s portfolio is anchored by the respiratory assets partnered with Glaxo Group Limited (GSK), including RELVAR/BREO ELLIPTA and ANORO ELLIPTA, which were jointly developed by Innoviva and GSK. Dec 19, 2016. Dec 2, 2016. Dec 2, 2016. Nov 21, 2016. 01/12/17 2:45 PM ET.
investor.invescointernational.co.uk
Private Investor - Invesco International - Home
Invesco Sterling Bond Fund. Key Investor Information Documents (KIIDs). Invesco Sterling Bond Fund. Implementation of FATCA rules at Invesco. Details about FATCA and how it may impact investors. Check fund availability in your country of residence. Send us an email. Tel: 353 1 439 8100. 38; Important information.
Davenport Online Log In
Davenport Online Log In. Remember My Login ID. 2018 Davenport and Company LLC Member : NYSE. Statement of Financial Condition.
